Symbol
PRME on Nasdaq
Investment type
Equity / Common Stock, $0.00001 par value
Latest Disclosed Ownership
6.11M shares
Security Ownership
4.7%

Newpath Partners, L.P. ownership in Prime Medicine, Inc. Common Stock, $0.00001 par value (PRME)

2025-02-14 - Newpath Partners, L.P. has filed an SCHEDULE 13G/A form with the Securities and Exchange Commission (SEC) disclosing ownership of 6.11M shares of Prime Medicine, Inc. Common Stock, $0.00001 par value (PRME). This represents 4.7% percent ownership of the company.